The APSANTICO Study: A Prospective Observational Study to Evaluate Antiphospholipid Antibody Profiles in Patients with Thromboembolic Antiphospholipid Syndrome (APS) after COVID-19 Infection and/or Vaccination.

MLA

Ott, Olivia, et al. “The APSANTICO Study: A Prospective Observational Study to Evaluate Antiphospholipid Antibody Profiles in Patients with Thromboembolic Antiphospholipid Syndrome (APS) after COVID-19 Infection and/or Vaccination.” International Journal of Molecular Sciences, vol. 24, no. 6, Mar. 2023. EBSCOhost, https://doi.org/10.3390/ijms24065644.

APA

Ott, O., Herrmann, E., Schulz, A., & Lindhoff-Last, E. (2023). The APSANTICO Study: A Prospective Observational Study to Evaluate Antiphospholipid Antibody Profiles in Patients with Thromboembolic Antiphospholipid Syndrome (APS) after COVID-19 Infection and/or Vaccination. International Journal of Molecular Sciences, 24(6). https://doi.org/10.3390/ijms24065644

Chicago

Ott, Olivia, Eva Herrmann, Annabel Schulz, and Edelgard Lindhoff-Last. 2023. “The APSANTICO Study: A Prospective Observational Study to Evaluate Antiphospholipid Antibody Profiles in Patients with Thromboembolic Antiphospholipid Syndrome (APS) after COVID-19 Infection and/or Vaccination.” International Journal of Molecular Sciences 24 (6). doi:10.3390/ijms24065644.